GO, pathway enrichment and PPI networks analysis of the overlapped genes revealed that LGZG decoction might attenuate NAFLD possibly by affecting insulin resistance and lipid metabolism related pathways (e.g., PI3K-Akt, AMPK). The gene discussed is PRKAB1; the disease is metabolic dysfunction-associated steatotic liver disease.